Our findings highlight that Cx43 hemichannels may represent a potential therapeutic target in alleviating sterile inflammation in late-stage CKD and build on observations that have identified a link between Cx43 expression and kidney damage. The gene discussed is GJA1; the disease is chronic kidney disease.